发明名称 |
crystalline [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy- 5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole- 1-heptanoic acid hemi calcium salt (atorvastatin) |
摘要 |
<p>Novel crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)- beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form I, Form II, and Form IV are characterized by their X-ray powder diffraction and/or solid state NMR are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia and hypercholesterolemia.</p> |
申请公布号 |
SK284202(B6) |
申请公布日期 |
2004.10.05 |
申请号 |
SK19980000062 |
申请日期 |
1996.07.08 |
申请人 |
WARNER-LAMBERT COMPANY |
发明人 |
BRIGGS CHRISTOPHER A.;JENNINGS REX ALLEN;WADE ROBERT A.;HARASAWA KIKUKO;ICHIKAWA SHIGERU;MINOHARA KAZUO;NAKAGAWA SHINSUKE |
分类号 |
C07D207/34;A61K31/40;A61P3/06;A61P3/14;A61P43/00;C07D;(IPC1-7):C07D207/34 |
主分类号 |
C07D207/34 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|